These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 9864272)

  • 1. Effects of P-glycoprotein modulators on etoposide elimination and central nervous system distribution.
    Burgio DE; Gosland MP; McNamara aPJ
    J Pharmacol Exp Ther; 1998 Dec; 287(3):911-7. PubMed ID: 9864272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cyclosporine A on the tissue distribution and pharmacokinetics of etoposide.
    Cárcel-Trullols J; Torres-Molina F; Araico A; Saadeddin A; Peris JE
    Cancer Chemother Pharmacol; 2004 Aug; 54(2):153-60. PubMed ID: 15114410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation effects of cyclosporine on etoposide pharmacokinetics and CNS distribution in the rat utilizing microdialysis.
    Burgio DE; Gosland MP; McNamara PJ
    Biochem Pharmacol; 1996 Apr; 51(7):987-92. PubMed ID: 8651950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of various cytochrome P450 3A and P-glycoprotein modulators on the biliary clearance of bromosulphaphthalein in male wistar rats.
    Machavaram KK; Gundu J; Yamsani MR
    Pharmazie; 2004 Dec; 59(12):957-60. PubMed ID: 15638086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a P-glycoprotein modulator on the pharmacokinetics and distribution of free levobupivacaine and bupivacaine in rats.
    Wu YT; Kao YL; Lin LC; Tsai TH
    Int J Pharm; 2010 Aug; 396(1-2):127-33. PubMed ID: 20600721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of capillary efflux transport inhibition on the determination of probe recovery during in vivo microdialysis in the brain.
    Sun H; Bungay PM; Elmquist WF
    J Pharmacol Exp Ther; 2001 Jun; 297(3):991-1000. PubMed ID: 11356921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug resistance-reversing agents increase vinblastine distribution in normal tissues expressing the P-glycoprotein but do not enhance drug penetration in brain and testis.
    Arboix M; Paz OG; Colombo T; D'Incalci M
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1226-30. PubMed ID: 9190857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced bioavailability of etoposide after oral or intravenous administration of etoposide with kaempferol in rats.
    Li C; Li X; Choi JS
    Arch Pharm Res; 2009 Jan; 32(1):133-8. PubMed ID: 19183886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible involvement of P-glycoprotein in renal excretion of pazufloxacin in rats.
    Shimizu A; Miyoshi M; Sugie M; Ueyama J; Yamaguchi T; Sasaki T; Takagi K; Jin M; Miyamoto K; Tsuji A; Hasegawa T
    Eur J Pharmacol; 2004 Oct; 501(1-3):151-9. PubMed ID: 15464074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of quercetin on the pharmacokinetics of Etoposide after oral or intravenous administration of etoposide in rats.
    Li X; Choi JS
    Anticancer Res; 2009 Apr; 29(4):1411-5. PubMed ID: 19414395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the influence of modulation of P-glycoprotein by a multiple dosing regimen of tamoxifen on the pharmacokinetics and toxicodynamics of doxorubicin.
    Darvari R; Boroujerdi M
    Cancer Chemother Pharmacol; 2005 Nov; 56(5):497-509. PubMed ID: 15937726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of morin on the pharmacokinetics of etoposide in rats.
    Li X; Yun JK; Choi JS
    Biopharm Drug Dispos; 2007 Apr; 28(3):151-6. PubMed ID: 17315145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo induction of hepatic p-glycoprotein by cyclosporine in the rat.
    Bai S; Liu J; Lu SK; Brunner LJ
    Res Commun Mol Pathol Pharmacol; 2001 Jul; 109(1-2):103-14. PubMed ID: 11458978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of etoposide elimination in the isolated perfused rat liver by Cremophor EL and Tween 80.
    Ellis AG; Crinis NA; Webster LK
    Cancer Chemother Pharmacol; 1996; 38(1):81-7. PubMed ID: 8603456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance.
    Lum BL; Kaubisch S; Yahanda AM; Adler KM; Jew L; Ehsan MN; Brophy NA; Halsey J; Gosland MP; Sikic BI
    J Clin Oncol; 1992 Oct; 10(10):1635-42. PubMed ID: 1403041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of pefloxacin and its interaction with cyclosporin A, a P-glycoprotein modulator, in rat blood, brain and bile, using simultaneous microdialysis.
    Tsai TH
    Br J Pharmacol; 2001 Mar; 132(6):1310-6. PubMed ID: 11250882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of effect of P-glycoprotein inhibition on renal clearance of dicloxacillin in patients with cystic fibrosis.
    Beringer PM; Kriengkauykiat J; Zhang X; Hidayat L; Liu S; Louie S; Synold T; Burckart GJ; Rao PA; Shapiro B; Gill M
    Pharmacotherapy; 2008 Jul; 28(7):883-94. PubMed ID: 18576903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of P-glycoprotein substrates and inhibitors among psychoactive compounds--implications for pharmacokinetics of selected substrates.
    El Ela AA; Härtter S; Schmitt U; Hiemke C; Spahn-Langguth H; Langguth P
    J Pharm Pharmacol; 2004 Aug; 56(8):967-75. PubMed ID: 15285840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of baicalin in rats and its interactions with cyclosporin A, quinidine and SKF-525A: a microdialysis study.
    Tsai PL; Tsai TH
    Planta Med; 2004 Nov; 70(11):1069-74. PubMed ID: 15549664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active transport of cimetidine and ranitidine into the milk of Sprague Dawley rats.
    McNamara PJ; Meece JA; Paxton E
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1615-21. PubMed ID: 8667230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.